Synonyms: E233 | MK-360
thiabendazole is an approved drug (FDA (1967))
Compound class:
Synthetic organic
Comment: Tiabendazole is a fungicide and parasiticide with potential anti-angiogenic (or vascular disrupting) action [1].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. FDA (1967) |
IUPAC Name ![]() |
2-(1,3-thiazol-4-yl)-1H-1,3-benzodiazole |
International Nonproprietary Names ![]() |
|
INN number | INN |
1436 | tiabendazole |
Synonyms ![]() |
E233 | MK-360 |
Database Links ![]() |
|
CAS Registry No. | 148-79-8 |
ChEMBL Ligand | CHEMBL625 |
DrugBank Ligand | DB00730 |
DrugCentral Ligand | 2621 |
GtoPdb PubChem SID | 178103877 |
PubChem CID | 5430 |
RCSB PDB Ligand | TMG |
Search Google for chemical match using the InChIKey | WJCNZQLZVWNLKY-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | WJCNZQLZVWNLKY |
Search PubMed clinical trials | tiabendazole |
Search PubMed titles | tiabendazole |
Search PubMed titles/abstracts | tiabendazole |
UniChem Compound Search for chemical match using the InChIKey | WJCNZQLZVWNLKY-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | WJCNZQLZVWNLKY-UHFFFAOYSA-N |
Wikipedia | Thiabendazole |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Thiabendazole (links to external site)
Cat. No. HY-B0263
Thiabendazole (Standard) (links to external site)
Cat. No. HY-B0263R |